Interestingly, patient number 36 presented with an EML4-ALK fusion based on PCR data, but FISH indicated that this patient was ALK rearrangement-negative since there were very few ALK rearrangement-positive cells (approximately 3%) in the tumor. This evidence concerns the gene EML4 and neoplasm.